Stay Updated
Press Releases
WASHINGTON, DC — Drug giant Merck’s pledge to cut prices for seven drugs and limit price hikes to no more than the rate of inflation was revealed to be little more than a PR stunt will do virtually nothing to alleviate the suffering of patients under the ever-increasing prices of Merck’s blockbuster drugs. “Merck gave […]
Press Releases
Don't be fooled by drug price hike pauses
WASHINGTON, DC — In response to the announcement that Novartis is temporarily postponing price increases for five months, Ben Wakana, Executive Director of Patients For Affordable Drugs, issued the following statement: “Let’s keep reality in focus: Drug companies don’t get credit for keeping prices high. Novartis and Pfizer temporarily postponed regularly scheduled price gouging — […]
Press Releases
Not enough: Pfizer roll backs on drug price hikes are not a significant drug pricing reform
WASHINGTON, DC — In response to the announcement that Pfizer rolled back July price hikes on dozens of prescription drugs after a presidential Tweet condemning the multinational drug corporation’s most recent price increases, David Mitchell, president and founder of Patients For Affordable Drugs, issued the following statement: “We’re glad to see that President Trump took […]
Press Releases
Patients For Affordable Drugs Delivers Petition Demanding Drug Giant Vertex Lower Its Prices
WASHINGTON, DC — Patients For Affordable Drugs delivered a 9,000-signature petition to Boston-based drugmaker Vertex that asked the company to lower the prices of its charity-funded cystic fibrosis drugs. The petition comes as ICER, a drug pricing watchdog, published an analysis on May 3 that said Vertex cystic fibrosis drugs are overpriced by at least […]
Press Releases
Patients For Affordable Drugs Sends U.S. Patients to United Nations
NEW YORK — Patients For Affordable Drugs will join academics, business leaders and representatives from 190 international organizations at a U.N General Assembly hearing today. P4AD Patient Advocates plan to ask attendees to consider drug prices when discussing prevention and control of non-communicable diseases. “A big barrier to the control and management of non-communicable diseases […]
Press Releases
Drug Corporations Ring in July with New Price Hikes
WASHINGTON, D.C. — July brought warm weather and new price hikes for Americans already struggling under unfair list prices. Pfizer announced price increases on 100 drugs, a move that comes as Americans continue to identify rising drug costs as a top priority for Congress. But Pfizer officials weren’t alone in thinking they could get away […]
Press Releases
Patient Group to House Democrats: Don’t Cut Bad Deal with Big Pharma
WASHINGTON, D.C. — “Don’t Get Fooled Again.” That’s the message from cancer patient and founder and president of Patients For Affordable Drugs David Mitchell to 50 Democratic members of the House. The members all signed on to a letter supporting drug corporations’ lobbying efforts to rollback Big Pharma’s contribution to Medicare that saves patients and taxpayers money. […]
Press Releases
Big Pharma's list prices are crushing America's seniors
WASHINGTON, DC — Seniors are filling fewer prescriptions for brand-named drugs, but they’re spending significantly more because list prices keep going up, according to a new government report. In response, David Mitchell, a cancer patient and founder of Patients For Affordable Drugs, issued the following statement: “Today’s report from the HHS Inspector General makes it […]